Quantbot Technologies LP Seres Therapeutics, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $23,994 - $55,470	-25,800 Reduced 51.19%	24,600 $34,000
Q3 2023 Nov 07, 2023	BUY	$2.33 - $5.07 $117,432 - $255,528	50,400 New	50,400 $119,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $177,609 - $249,217	-28,192 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $169,715 - $322,234	28,192 New	28,192 $234,000
Q2 2021 Aug 12, 2021	SELL	$18.46 - $24.36 $38,766 - $51,156	-2,100 Closed	0 $0

Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $22,958 - $37,596	1,300 Added 162.5%	2,100 $43,000
Q4 2020 Feb 12, 2021	SELL	$23.25 - $37.73 $23,250 - $37,730	-1,000 Reduced 55.56%	800 $19,000
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $6,732 - $51,732	1,800 New	1,800 $50,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.